APA

Rudick R. A., Simonian N. A., Alam J. A., Campion M., Scaramucci J. O., Jones W., Coats M. E., Goodkin D. E., Weinstock-Guttman B., Herndon R. M., Mass M. K., Richert J. R., Salazar A. M., Munschauer F. E., Cookfair D. L., Simon J. H. & Jacobs L. D. (19980608). Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG). : Neurology.

Chicago

Rudick R A, Simonian N A, Alam J A, Campion M, Scaramucci J O, Jones W, Coats M E, Goodkin D E, Weinstock-Guttman B, Herndon R M, Mass M K, Richert J R, Salazar A M, Munschauer F E, Cookfair D L, Simon J H and Jacobs L D. 19980608. Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG). : Neurology.

Harvard

Rudick R. A., Simonian N. A., Alam J. A., Campion M., Scaramucci J. O., Jones W., Coats M. E., Goodkin D. E., Weinstock-Guttman B., Herndon R. M., Mass M. K., Richert J. R., Salazar A. M., Munschauer F. E., Cookfair D. L., Simon J. H. and Jacobs L. D. (19980608). Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG). : Neurology.

MLA

Rudick R A, Simonian N A, Alam J A, Campion M, Scaramucci J O, Jones W, Coats M E, Goodkin D E, Weinstock-Guttman B, Herndon R M, Mass M K, Richert J R, Salazar A M, Munschauer F E, Cookfair D L, Simon J H and Jacobs L D. Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG). : Neurology. 19980608.